jocelynhudson

22 POSTS 0 COMMENTS

CE mark for Watchman FLX left atrial appendage closure device

Boston Scientific announced it has received CE mark and initiated a limited market release of the next generation Watchman FLX left atrial appendage closure...

Vascular Dynamics names Martin Rothman chief medical officer

Martin T Rothman has been appointed as chief medical officer of Vascular Dynamics, effective 1 January 2019. Rothman is a pioneer in interventional cardiology, as...

Vascular Dynamics names Martin Rothman chief medical officer

Martin T Rothman has been appointed as chief medical officer of Vascular Dynamics, effective 1 January 2019. Rothman is a pioneer in interventional cardiology, as...

Philips launces Azurion with FlexArm to aid image-guided procedures

Philips launches its Azurion with FlexArm to aid patient imaging and positioning during image-guided procedures. During increasingly complex interventions, clinicians need to quickly and easily...

Positive results for LivaNova’s Perceval sutureless valve

Three newly published studies highlight the safety, efficacy, and economic advantage of the Pervecal sutureless aortic valve (LivaNova). The results from the Perceval Aortic...

Abbott to acquire Cephea Valve Technologies

It was recently announced that Abbott has exercised its option to purchase Cephea Valve Technologies. Financial terms were not disclosed. Abbott provided capital and...

New JACC publication reinforces valve of a coronary CTA + HeartFlow...

HeartFlow has announced the publication of the PACIFIC substudy showing that their FFRct Analysis demonstrates the highest diagnostic performance for detecting coronary artery disease...

JenaValve Technology appoints John T Kilcoyne as chief executive officer

Medical device executive John T Kilcoyne has been appointed as chief executive officer of JenaValve Technology, effective immediately. In addition, he will serve as...

Shockwave initiates US pivotal study for coronary intravascular lithotripsy

  Shockwave Medical has initiated its US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study—DISRUPT CAD III—for the use of Intravascular Lithotripsy (IVL)...

First patients in the Middle East treated with Diamondback 360 Coronary...

  The first patients in the United Arab Emirates (UAE) have been treated with the Diamondback 360 Coronary Orbital Atherectomy System (OAS; Cardiovascular Systems). The first UAE...

Sleeping less than six hours a night may increase cardiovascular risk

People who sleep less than six hours a night may be at increased risk of cardiovascular disease compared with those who sleep between seven...

FDA approves world’s first device for treatment of premature babies and...

The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), the world's first medical device that can be implanted in...

Boston Scientific, Edwards Lifesciences agree to global litigation settlement

Boston Scientific and Edwards Lifesciences today announced that the companies have reached an agreement to settle all outstanding patent disputes between the companies in...

Does your insurance card matter when you have a heart attack?

Medicaid reimbursement to healthcare facilities on ST-elevation myocardial management—or STEMI, a serious form of a heart attack—is often lower when compared with the reimbursement...

SCCT releases new guideline for use of computed tomography in TAVR...

The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus document for computed tomography imaging to improve outcomes for patients undergoing...

Patient recruitment reaches half-way point for global DAPT study

December marked a significant milestone for a major study into the use of short duration dual anti-platelet therapy (DAPT) in high bleeding risk patients...

First United States treatment with J-Valve TAVI device

The first US patient has been successfully treated with JC Medical's transfemoral transcatheter aortic valve implantation (TAVI) device, the J-Valve TF system. The patient...

Sapien 3 Ultra receives FDA approval

It has been announced that the Sapien 3 Ultra system (Edwards Lifesciences) has received US FDA approval for transcatheter aortic valve implantation (TAVI) in...

Internationally renowned cardiac surgeon joins University of Miami Health System

Joseph Lamelas, an internationally recognised expert cardiac surgeon who helped pioneer minimally invasive approaches to cardiac surgery, has joined the University of Miami Health...

FFRangio system receives US FDA clearance

US FDA 510(k) clearance has been granted for the FFRangio System (CathWorks). The FFRangio system demonstrated accuracy versus the invasive FFR wire in a...

Boston Scientific exercises option to acquire Millipede

Boston Scientific has exercised its option to acquire the remaining shares of Millipede, upon its recent successful completion of a first-in-human clinical study. The...

First patients treated in United States with OrbusNeich Teleport Microcatheter

The first patients in the United States have been treated using the OrbusNeich Teleport Microcatheter (Teleport; Cardiovascular Systems), which recently received US Food and...